| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Tnf - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN317964LP | 1 kit | ORIGENE TECHNOLOGIES |
| Tnf - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN317964RB | 1 kit | ORIGENE TECHNOLOGIES |
| TNF receptor-associated factor 1 (TRAF1) from ORIGENE TECHNOLOGIES | LY417149 | 100 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor (erythroid-derived 2), 45kDa (NFE2) from ORIGENE TECHNOLOGIES | TP302924 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP304140 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760529 | 50 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor (erythroid-derived 2), 45kDa (NFE2), transcript variant 2, full length from ORIGENE TECHNOLOGIES | TP761189 | 50 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor I/A (NFIA), transcript variant 1 from ORIGENE TECHNOLOGIES | TP325878 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor I/A (NFIA), transcript variant 2 from ORIGENE TECHNOLOGIES | TP304650 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor I/C (CCAAT-binding transcription factor) (NFIC), transcript variant 1 from ORIGENE TECHNOLOGIES | TP304184 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor, interleukin 3 regulated (NFIL3), full length from ORIGENE TECHNOLOGIES | TP761191 | 50 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor I/B (NFIB) from ORIGENE TECHNOLOGIES | TP301590 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATC1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP311136 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (NFATC2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP315180 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (NFATC2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP313966 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 (NFATC3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP300357 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 (NFATC4), transcript variant 1 from ORIGENE TECHNOLOGIES | TP326608 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (NFATC2), transcript variant D from ORIGENE TECHNOLOGIES | TP326803 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA) from ORIGENE TECHNOLOGIES | TP300711 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (NFKBIB), transcript variant 1 from ORIGENE TECHNOLOGIES | TP302182 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (NFKBIB), transcript variant 2 from ORIGENE TECHNOLOGIES | TP318695 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta (NFKBID) from ORIGENE TECHNOLOGIES | TP311589 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon (NFKBIE) from ORIGENE TECHNOLOGIES | TP760703 | 50 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 (NFKBIL1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP311251 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1) from ORIGENE TECHNOLOGIES | TP308384 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP313313 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2), transcript variant 3 from ORIGENE TECHNOLOGIES | TP301147 | 20 ug | ORIGENE TECHNOLOGIES |
| Human nuclear import 7 homolog (S. cerevisiae) (NIP7) from ORIGENE TECHNOLOGIES | TP720548 | 10 ug | ORIGENE TECHNOLOGIES |
| Vasoactive intestinal peptide (VIP), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405128 | 100 ug | ORIGENE TECHNOLOGIES |
| Vasodilator-stimulated phosphoprotein (VASP) from ORIGENE TECHNOLOGIES | LY401150 | 100 ug | ORIGENE TECHNOLOGIES |
| Vasohibin 1 (VASH1) from ORIGENE TECHNOLOGIES | LY414940 | 100 ug | ORIGENE TECHNOLOGIES |
| Vasohibin 2 (VASH2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411100 | 100 ug | ORIGENE TECHNOLOGIES |
| Vasohibin 2 (VASH2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427885 | 100 ug | ORIGENE TECHNOLOGIES |
| Vasohibin 2 (VASH2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427886 | 100 ug | ORIGENE TECHNOLOGIES |
| Vasorin (VASN) from ORIGENE TECHNOLOGIES | LY408694 | 100 ug | ORIGENE TECHNOLOGIES |
| VASP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403544 | 1 kit | ORIGENE TECHNOLOGIES |
| Vasp - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518858 | 1 kit | ORIGENE TECHNOLOGIES |
| VASP Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303544 | 10 ug | ORIGENE TECHNOLOGIES |
| VAT1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402201 | 1 kit | ORIGENE TECHNOLOGIES |
| Vat1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518859 | 1 kit | ORIGENE TECHNOLOGIES |
| VAT1L - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407266 | 1 kit | ORIGENE TECHNOLOGIES |
| Vat1l - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518860 | 1 kit | ORIGENE TECHNOLOGIES |
| VAT1L Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH307266 | 10 ug | ORIGENE TECHNOLOGIES |
| VAT1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302201 | 10 ug | ORIGENE TECHNOLOGIES |
| Vav 1 guanine nucleotide exchange factor (VAV1) from ORIGENE TECHNOLOGIES | LY417322 | 100 ug | ORIGENE TECHNOLOGIES |
| Vav 2 guanine nucleotide exchange factor (VAV2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418726 | 100 ug | ORIGENE TECHNOLOGIES |
| Vav 3 guanine nucleotide exchange factor (VAV3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416860 | 100 ug | ORIGENE TECHNOLOGIES |
| Vav 3 guanine nucleotide exchange factor (VAV3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421571 | 100 ug | ORIGENE TECHNOLOGIES |
| VAV2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416175 | 1 kit | ORIGENE TECHNOLOGIES |
| VAV3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418352 | 1 kit | ORIGENE TECHNOLOGIES |